Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
about
Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsAdvances in the epidemiology of heart failure and left ventricular remodelingNeutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeuticsWDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac FunctionBrain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentInnovative Therapeutics: Designer Natriuretic Peptides.Designer natriuretic peptides.A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertensionNovel natriuretic peptides: new compounds and new approaches.Advances in oral macromolecular drug delivery.Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats.Is natriuretic peptide receptor C a new target for hypertension therapeutics?A new signal from B-type natriuretic peptide in ST-elevation myocardial infarction: what does it mean for B-type natriuretic peptide and innovative diagnostics?
P2860
Q26778333-B5AA3995-2FD8-4D04-A442-5F344F8EEF98Q26827147-5FF5C260-5267-4E96-8154-74513C17E249Q27004000-2D800E4B-B2C6-4A93-8567-6B889A3D78F1Q28261222-C7B4DBFC-C039-45F6-B452-C5E2D0A2C4ECQ33573360-009123EE-0EA1-4956-8F78-D9F1A86BCBB7Q33653332-7534B770-6979-49E6-B2C3-5BF5EF76C5BAQ35086479-ABC0AB5B-668F-4DC8-95AF-975CC7A3C65EQ35283673-0F73A535-AC36-48A3-AE26-90BFE1A7C643Q35659994-C65267D3-C84E-46ED-88E8-9AECD08EEE54Q37815438-D37E6AA4-6EB8-4A07-9486-6127726F5A7AQ38235506-9B939008-35B1-4BB1-AC03-2128A0612D80Q38261513-3355FB78-222B-4AA9-9E62-D0C378A7A374Q38934765-1FC5A834-D2BF-403A-8D3D-0966C1C4E131Q42394649-0FBB3AEA-68A1-4C77-8687-A9BDE510D038Q42874933-D7EFA7A0-5F09-41BF-B147-23CC1C1E4CEE
P2860
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@en
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@nl
type
label
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@en
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@nl
prefLabel
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@en
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@nl
P2093
P2860
P1433
P1476
Chronic actions of a novel ora ...... nsin II-mediated hypertension.
@en
P2093
Alessandro Cataliotti
Fernando L Martin
Guido Boerrigter
Horng H Chen
John A Schirger
John C Burnett
Karen Polowy
Kenneth D James
Kent R Bailey
Lisa C Costello-Boerrigter
P2860
P304
P356
10.1161/CIRCULATIONAHA.107.759241
P407
P577
2008-10-06T00:00:00Z